These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25903471)

  • 1. Which factors influence the resort to surrogate consent in stroke trials, and what are the patient outcomes in this context?
    Mendyk AM; Labreuche J; Henon H; Girot M; Cordonnier C; Duhamel A; Leys D; Bordet R
    BMC Med Ethics; 2015 Apr; 16():26. PubMed ID: 25903471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Experience of Surrogate Decision Makers on Being Approached for Consent for Patient Participation in Research. A Multicenter Study.
    Burns KE; Prats CJ; Maione M; Lanceta M; Zubrinich C; Jeffs L; Smith OM;
    Ann Am Thorac Soc; 2017 Feb; 14(2):238-245. PubMed ID: 27849142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of individual clinical outcomes on trial participants' perspectives on enrollment in emergency research without consent.
    Whitesides LW; Baren JM; Biros MH; Fleischman RJ; Govindarajan PR; Jones EB; Pancioli AM; Pentz RD; Scicluna VM; Wright DW; Dickert NW
    Clin Trials; 2017 Apr; 14(2):180-186. PubMed ID: 28359192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection bias in clinical stroke trials depending on ability to consent.
    Hotter B; Ulm L; Hoffmann S; Katan M; Montaner J; Bustamante A; Meisel A
    BMC Neurol; 2017 Dec; 17(1):206. PubMed ID: 29202730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practice.
    Rosenbaum JR; Bravata DM; Concato J; Brass LM; Kim N; Fried TR
    Stroke; 2004 Sep; 35(9):e353-5. PubMed ID: 15243145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical issues of informed consent in acute stroke. Analysis of the modalities of consent in 56 patients enrolled in urgent therapeutic trials.
    Demarquay G; Derex L; Nighoghossian N; Adeleine P; Philippeau F; Honnorat J; Trouillas P
    Cerebrovasc Dis; 2005; 19(2):65-8. PubMed ID: 15644623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of informed consent on patient characteristics in a stroke thrombolysis trial.
    Thomalla G; Boutitie F; Fiebach JB; Simonsen CZ; Nighoghossian N; Pedraza S; Lemmens R; Roy P; Muir KW; Heesen C; Ebinger M; Ford I; Cheng B; Cho TH; Puig J; Thijs V; Endres M; Fiehler J; Gerloff C
    Neurology; 2017 Sep; 89(13):1400-1407. PubMed ID: 28842449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Documentation of decision-making capacity, informed consent, and health care proxies: a study of surrogate consent.
    Glezer A; Stern TA; Mort EA; Atamian S; Abrams JL; Brendel RW
    Psychosomatics; 2011; 52(6):521-9. PubMed ID: 22054621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of Patient and Surrogate Experiences With Acute Care Research Consent: A Key Informant Interview Study.
    Scicluna VM; Goldkind SF; Mitchell AR; Pentz RD; Speight CD; Silbergleit R; Dickert NW
    J Am Heart Assoc; 2019 Nov; 8(22):e012599. PubMed ID: 31698980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surrogate consent for dementia research: a national survey of older Americans.
    Kim SY; Kim HM; Langa KM; Karlawish JH; Knopman DS; Appelbaum PS
    Neurology; 2009 Jan; 72(2):149-55. PubMed ID: 19139366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic stroke survivors' opinion regarding research utilizing exception from informed consent.
    Kleindorfer D; Lindsell CJ; Alwell K; Woo D; Flaherty ML; Eilerman J; Khatri P; Adeoye O; Ferioli S; Kissela BM
    Cerebrovasc Dis; 2011; 32(4):321-6. PubMed ID: 21921594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive symptoms in stroke patients: a 13 month follow-up study of patients referred to a rehabilitation unit.
    Farner L; Wagle J; Engedal K; Flekkøy KM; Wyller TB; Fure B
    J Affect Disord; 2010 Dec; 127(1-3):211-8. PubMed ID: 20933286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective Consent to Hemicraniectomy after Malignant Stroke among the Elderly, Despite Impaired Functional Outcome.
    Ragoschke-Schumm A; Junk C; Lesmeister M; Walter S; Behnke S; Schumm J; Fassbender K
    Cerebrovasc Dis; 2015; 40(5-6):286-92. PubMed ID: 26509666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological Deficits in Stroke Patients that May Impede the Capacity to Provide Informed Consent for Endovascular Treatment Trials.
    Janssen PM; Chalos V; van den Berg SA; Kompanje EJO; Nederkoorn PJ; van der Worp BH; van Zwam WH; Dippel DWJ;
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104447. PubMed ID: 31624035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deliberating clinical research with cognitively impaired older people and their relatives: an ethical add-on study to the protocol "Effects of Temporary Discontinuation of Antihypertensive Treatment in the Elderly (DANTE) with Cognitive Impairment".
    van Rookhuijzen AE; Touwen DP; de Ruijter W; Engberts DP; van der Mast RC
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1233-40. PubMed ID: 23973250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A computer-based education intervention to enhance surrogates' informed consent for genomics research.
    Shelton AK; Freeman BD; Fish AF; Bachman JA; Richardson LI
    Am J Crit Care; 2015 Mar; 24(2):148-55. PubMed ID: 25727275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain lesion volume and capacity for consent in stroke trials: potential regulatory barriers to the use of surrogate markers.
    Dani KA; McCormick MT; Muir KW
    Stroke; 2008 Aug; 39(8):2336-40. PubMed ID: 18535280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How important is surrogate consent for stroke research?
    Flaherty ML; Karlawish J; Khoury JC; Kleindorfer D; Woo D; Broderick JP
    Neurology; 2008 Nov; 71(20):1566-71. PubMed ID: 18753472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.